COVID-19 and vitamin D supplementation: Is there any evidence based to reduce the risk?
Copyright © 2020 Authors
This work is licensed under a Creative Commons Attribution 4.0 International License.
- Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
Several studies and meta-analysis suggest that vitamin D deficiency constitutes a risk factor for acute respiratory infections while supplementation may reduce this risk. Given the current context of the COVID-19 pandemic, the role of vitamin D supplementation in the prevention and improvement of the prognosis of affected patients has been suggested by some studies and refuted by others. Through this article, we report the mechanisms of action and properties of vitamin D, and we discuss the different hypotheses of the involvement of vitamin D in respiratory infections, especially Covid-19 in the light of the most recent published data.
Keywords
How to Cite
Similar Articles
- Pica in sickle cell disease: nutritional management and implications
- Regulation of food supplements in Algeria: Current situation, issues, and perspectives.
- Bioactive molecules of grape
- Nutrition situation of Burkina Faso: a narrative review
- Impact of incorporating sesame oil (Sesamum indicum L.) in an Algerian frying oil and margarine formulation
- Effects of complementary food formulated from millet, soybean, and grasshopper on hematological parameters of malnourished weanling albino rats
- Neurotoxic and neuromotor effects of cyanate, an oxidative byproduct of cyanide from linamarin in cassava: A systematic review
- Olive stone as a sustainable agricultural by-product: Valorization pathways and prospects in food and feed Industries
- Association between dietary diversity and nutritional status of children aged 6-59 months in the Tamale Metropolis
- Comparative Nutritional Characterization of a Novel Formulated Composite Milk Alternative and a Conventional Infant Formula : (Corrected Proof)
You may also start an advanced similarity search for this article.
NAJFNR is licensed under 